文献速递糖尿病

INPUT教育项目对胰岛素泵治疗患者的疗效:随机对照试验结果

Efficacy of an Education Program for People With Diabetes and Insulin Pump Treatment (INPUT): Results From a Randomized Controlled Trial.
PubMed 文献 · Diabetes Care · 2018-10-10

本研究为多中心随机平行对照试验,纳入268例胰岛素泵治疗患者,随机分为INPUT结构化教育组和常规护理组,随访6个月。结果显示INPUT组HbA1c显著改善,组间差异为-0.22%(95%CI -0.38至-0.06,P=0.0029),且严重低血糖发生率显著低于对照组(发生率比3.55,95%CI 1.50-8.43,P=0.0041)。

要点

  • INPUT结构化教育可显著降低胰岛素泵用户的HbA1c水平。
  • INPUT组严重低血糖发生率显著低于常规护理组。
  • 需为胰岛素泵用户提供结构化教育以改善血糖控制和安全性。

核心结论

  • INPUT教育项目显著改善了胰岛素泵用户的血糖控制并降低了严重低血糖发生率。

研究设计与样本

  • 多中心、随机、平行对照试验,随访6个月,纳入年龄16-75岁、正在使用胰岛素泵治疗的糖尿病患者268例,按1:1随机分为INPUT组(n=135)和常规护理组(n=133),以研究中心为分层因素。

主要发现

  • 6个月时INPUT组HbA1c从8.33±0.8%降至8.04±0.9%(P<0.0001),对照组从8.33±1.0%降至8.27±1.0%(P=0.11)。
  • 组间HbA1c降低差异显著, favoring INPUT(-0.28% vs. -0.06%,Δ -0.22%,95%CI -0.38至-0.06;P=0.0029)。
  • 对照组严重低血糖发生率是INPUT组的3.55倍(95%CI 1.50-8.43;P=0.0041)。

临床怎么用

  • 对于使用胰岛素泵的糖尿病患者,应考虑实施INPUT结构化教育项目以改善血糖控制并减少严重低血糖风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Continuous subcutaneous insulin infusion (CSII) is the most advanced form of insulin delivery, but it requires structured education to provide users with the necessary knowledge/skills and to support their motivation. Currently, no structured education program designed to provide this training has been evaluated. We developed a CSII-specific, structured education program (Insulin Pump Treatment [INPUT]) and evaluated its impact on glycemic control, behavior, and psychosocial status. RESEARCH DESIGN AND METHODS: This was a multicenter, randomized, parallel trial with a 6-month follow-up. Eligible participants (age 16-75 years) currently were treated with insulin pump therapy. Participants were randomly assigned (1:1) to the INPUT program or to usual care using a computer-generated algorithm, with study center as the stratification factor. The primary outcome was HbA1c change from baseline to 6 months. Secondary outcomes were incidence of severe hypoglycemia and changes in behavioral and psychosocial measures. RESULTS: Between 1 April 2016 and 26 April 2016, 268 people with diabetes and a mean duration of CSII therapy of 9.5 years were randomly assigned to the INPUT group (n = 135) or control group (n = 133). At 6 months, HbA1c improved in the INPUT group (8.33 ± 0.8 vs. 8.04 ± 0.9; P < 0.0001) but not in the control group (8.33 ± 1.0 vs. 8.27 ± 1.0; P = 0.11). The between-group difference in HbA1c reduction was significant, favoring INPUT (-0.28% vs. -0.06%, Δ -0.22%, 95% CI -0.38 to -0.06; P = 0.0029). The incidence rate ratio of severe hypoglycemia was 3.55 times higher for participants in the control group than for those in the INPUT group (95% CI 1.50-8.43; P = 0.0041). CONCLUSIONS: The INPUT education program led to a significant improvement in glycemic control and incidence of severe hypoglycemia in insulin pump users.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ehrmann D, Kulzer B, Schipfer M, et al. Efficacy of an Education Program for People With Diabetes and Insulin Pump Treatment (INPUT): Results From a Randomized Controlled Trial. Diabetes Care. 2018. PMID: 30305343. doi:10.2337/dc18-0917

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。